On Friday, the FDA approved Checkpoint Therapeutics, Inc.’s (NASDAQ:CKPT) Unloxcyt (cosibelimab-ipdl) for metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not ...
The best point and shoot camera needs to be small enough to fit a pocket, and affordable enough to be kind to it! Having the best point-and-shoot camera is really handy if you don't want to carry ...
Another checkpoint inhibitor has entered the fray, as Checkpoint Therapeutics has passed the FDA’s checkpoint with its PD-L1 inhibitor cosibelimab. The FDA has approved cosibelimab under the ...
“Today’s FDA approval of Unloxcyt – the first marketing approval for our company…This approval marks Checkpoint’s transformation to a commercial-stage company, with the opportunity to ...
JERUSALEM, Dec 16 (Reuters) - Check Point Software Technologies (CHKP.O), opens new tab said on Monday that Nadav Zafrir has taken over as chief executive, replacing Gil Shwed who had been CEO for ...